Patents Represented by Attorney Walter H. Schneider
  • Patent number: 5750149
    Abstract: Pharmaceutical and/or dermocosmetic compositions containing equine colostrum, optionally in admixture with milk.
    Type: Grant
    Filed: August 14, 1995
    Date of Patent: May 12, 1998
    Assignee: Horse Vitality Ltd
    Inventor: Rosa Maria Gobbi
  • Patent number: 5663479
    Abstract: Halogenated contaminants are decomposed in a fluid and solid by reacting such matrix with a reagent composed of a non-alkali metal, a polyalkyleneglycol/or Nixolens.sup.R and a hydroxide/or alcoholate. Further, this reagent combined with certain solid carriers forms an immobilized decontamination bed to remove halogenated contaminants continuously from a fluid.
    Type: Grant
    Filed: June 12, 1995
    Date of Patent: September 2, 1997
    Assignee: Sea Marconi Technologies di Wander Tumiatti S.A.S.
    Inventor: Wander Tumiatti
  • Patent number: 5607674
    Abstract: Utilization of the Tarchanthus camphoratus and its derivatives in formulations and compositions having insect repellant, anti-irritant, anti-edema, decongestant and soothing properties.
    Type: Grant
    Filed: July 10, 1995
    Date of Patent: March 4, 1997
    Assignee: Gisquare Technologies B.V.
    Inventors: Guido Rovesti, Gabriele Segalla, Pietro La Fratta, Michele G. Di Schiena
  • Patent number: 5587390
    Abstract: Imidazole derivatives having A II antagonist activity, of Formula I, the processes for the preparation thereof, pharmaceutical compositions containing them and the use thereof as therapeutic agents. The described compounds having A II antagonist activity can be used in various cardiovascular disorders.
    Type: Grant
    Filed: March 17, 1995
    Date of Patent: December 24, 1996
    Assignee: Istituto Luso Farmaco D'Italia S.p.A.
    Inventors: Aldo Salimbeni, Fabio Paleari, Jacques Mizrahi, Carlo Scolastico
  • Patent number: 5514365
    Abstract: A method for treating a patient suffering from any of osteoporosis, Paget's disease and hypercalcemia by intranasally administering to said patient by spray a calcitonin solution consisting of calcitonin dissolved in a 0.9% aqueous sodium chloride solution free of quaternary ammonium compounds and surfactants, the calcitonin being in a concentration of 100-5000 IU per ml. of composition.
    Type: Grant
    Filed: April 25, 1994
    Date of Patent: May 7, 1996
    Assignee: Schiapparelli Salute S.p.A.
    Inventors: Salvatore Mardente, Rodolfo Corneli, Marilena Carazzone
  • Patent number: 5380710
    Abstract: Pharmaceutical compositions containing ACTH(1-24) are effective in the treatment of shock conditions and of respiratory and cardiocirculatory insufficiency. The compositions of the invention may be administered by parenteral or inhalatory route at a dosage ranging from 1 to 10 mg of active principle.
    Type: Grant
    Filed: October 11, 1990
    Date of Patent: January 10, 1995
    Inventor: Alfio Bertolini
  • Patent number: 5321019
    Abstract: Compounds of formula I: ##STR1## in which the various R groups have the meanings defined in the disclosure are useful as medicaments for the treatment of hepatobiliary diseases.
    Type: Grant
    Filed: January 11, 1993
    Date of Patent: June 14, 1994
    Assignee: Giuliani S.p.A.
    Inventors: Giangermano Giuliani, Giuliano Frigerio, Roberto Pellicciari
  • Patent number: 5286851
    Abstract: Monoclonal antibodies able to selectively bind to doxorubicin and its analogues and derivatives are disclosed.
    Type: Grant
    Filed: November 15, 1988
    Date of Patent: February 15, 1994
    Assignee: Istituto Nazionale per lo Studio e la Cura Dei Tumori
    Inventors: Andrea Balsari, Maria I. Colnagh, Mario Ghione
  • Patent number: 5250719
    Abstract: A process for the purification of glycerylphosphorylcholine (GPC) and glycerylphosphorylethanolamine (GPE) from crude mixtures by eluting the latter on a cationic resin in acid form equilibrated in an anhydrous solvent, washing the resin with alcohol or a hydrated mixture thereof followed by washing with water, and then eluting on a strong basic resin in OH form to separate purified GPC and GPE.
    Type: Grant
    Filed: November 8, 1991
    Date of Patent: October 5, 1993
    Assignee: Prime European Therapeuticals S.p.A.
    Inventor: Giovanni Tronconi
  • Patent number: 5212160
    Abstract: 3-L-(5-thioxo-L-prolyl)thiazolidine-4-carboxylic acid and the derivatives thereof have valuable immunostimulating, antioxidant, antiradical and antiageing properties. They are prepared by thionating the corresponding 3-L-pyroglutamyl-L-thiazolidine-4-carboxylic acid derivatives or by condensing 5-thioxo-L-proline with the corresponding L-thiazolidine-4-carboxylic acid derivatives.
    Type: Grant
    Filed: January 16, 1991
    Date of Patent: May 18, 1993
    Assignee: Poli Industria Chimica S.p.A.
    Inventors: Stefano Poli, Lucio Del Corona, Germano Coppi
  • Patent number: 5180850
    Abstract: A new crystalline form of magnesium valproate obtained by reacting valproic acid with magnesium alkoxides in alcoholic solution is described.The new crystalline form is endowed with enhanced bioavailability and may be used in a particularly pure form to prepare pharmaceutical compositions which are useful for treating Central Nervous System pathologies.
    Type: Grant
    Filed: December 13, 1990
    Date of Patent: January 19, 1993
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventor: Claudio Cavazza
  • Patent number: 5177016
    Abstract: A monoclonal antibody against Doxorubicin and other anthracycline derivatives, being the monoclonal antibody able to selectively recognize epitopes located in correspondence or in proximity of the aromatic D ring of the anthracycline molecule, is described.
    Type: Grant
    Filed: January 16, 1991
    Date of Patent: January 5, 1993
    Assignee: Istituto Nazionale per lo Studio e la Cura dei Tumori
    Inventors: Andrea Balsari, Maria I. Colnaghi, Mario Ghione
  • Patent number: 5175320
    Abstract: Compounds of general formula I ##STR1## wherein R.sub.1 is hydrogen or hydroxy, and the hydroxy group at the 7-position can be either in .alpha. or .beta. configuration, are valuable in human therapy. Compounds I can be prepared by fluorination of the suitably protected 6.alpha.-hydroxy-7-keto-derivatives.
    Type: Grant
    Filed: September 18, 1991
    Date of Patent: December 29, 1992
    Assignee: Giuliani S.p.A.
    Inventors: Roberto Pellicciari, Aldo Roda, Giuliano Frigerio
  • Patent number: 5166374
    Abstract: Compounds of general formula I ##STR1## wherein R.sub.1 is hydrogen or hydroxy, and the hydroxy group at the 7-position can be either in .alpha. or .beta. configuration, are valuable in human therapy. Compounds I can be prepared by reacting with succinic acid carboanions the corresponding derivatives which have previously been protected, and subsequently deprotecting and decarboxylating them.
    Type: Grant
    Filed: September 18, 1991
    Date of Patent: November 24, 1992
    Assignee: Giuliani S.p.A.
    Inventors: Roberto Pellicciari, Aldo Roda, Giuliano Frigerio
  • Patent number: 5130061
    Abstract: A process for the extraction of eicosapentaenoic (EPA) and docosahexaenoic (DHA) acid esters from crude fish oils, by means of transesterification with ethanol and H.sub.2 SO.sub.4 and two-step molecular distillation.
    Type: Grant
    Filed: May 24, 1989
    Date of Patent: July 14, 1992
    Assignee: Innova di Ridolfi Flora & C. s.a.s.
    Inventors: Franco Cornieri, Walter Di Fulvio
  • Patent number: 5110936
    Abstract: 3-(L-pyroglutamyl)-L-thiazolidine-4-carboxylic acid and derivatives thereof are prepared by condensing L-pyroglutamic acid or its substitution products, either in the presence of dicyclohexylcarbodiimmide or the like, or by condensation of active derivatives of L-pyroglutamic acid with 4-thiazolidine-carboxylic acid derivatives.
    Type: Grant
    Filed: October 9, 1990
    Date of Patent: May 5, 1992
    Assignee: Roli Industria Chimica S.p.A.
    Inventors: Stefano Poli, Lucio Del Corona
  • Patent number: 5096898
    Abstract: Bile acid derivatives of formula I ##STR1## wherein: R is hydrogen or hydroxy;X is a carboxy or a SO.sub.3 H group, have valuable pharmacologic properties.
    Type: Grant
    Filed: February 5, 1991
    Date of Patent: March 17, 1992
    Assignee: Giuliani S.p.A.
    Inventors: Roberto Pellicciari, Aldo Roda
  • Patent number: 5093472
    Abstract: The present invention relates to an acrylic acid synthetic polymer, said polymer being cross-linked, having high molecular weight and containing 56% to 68% by weight carboxy groups (--COOH), characterized in that it contains no more than 10 ppm solvent; and to a process for the preparation thereof.
    Type: Grant
    Filed: January 16, 1990
    Date of Patent: March 3, 1992
    Assignee: Sigma Prodotti Chimici S.r.l.
    Inventor: Angelo Bresciani
  • Patent number: 5073354
    Abstract: Gold and silver are stripped from activated carbon on which they are adsorbed as cyanide complexes by subjecting the activated carbon to a stripping solution comprising as the strippant an effective amount of a compound containing the carboxylate functionality. The compound is preferably selected from benzoic and substituted benzoic acids, and polyacrylic acids of less than about 100,000 m.w.
    Type: Grant
    Filed: September 26, 1990
    Date of Patent: December 17, 1991
    Assignee: Drew Chemical Corporation
    Inventors: Everett J. Fuller, Lionel B. Luttinger, Mark G. Lang
  • Patent number: D326116
    Type: Grant
    Filed: October 5, 1989
    Date of Patent: May 12, 1992
    Inventor: Johannes C. van Wirst